Evidence map›Paper›PMID 26013383›Full record

ArticleMolecules and cells2015

Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.

Ki Yeon Kim, Gwanghee Lee, Minsang Yoon, Eun Hye Cho, Chan-Sik Park, Moon Gyo Kim

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. cGAMP the travelling messenger.Frontiers in immunology · 2023
    Review
  5. Article
  6. Article
  7. Activity of Tracheal Cytotoxin ofFrontiers in cellular and infection microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ki Yeon KimDepartment of Biological Sciences, Inha University, Incheon 402-720, Korea.
Gwanghee LeeDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Minsang YoonDepartment of Biological Sciences, Inha University, Incheon 402-720, Korea.
Eun Hye ChoDepartment of Biological Sciences, Inha University, Incheon 402-720, Korea.
Chan-Sik ParkDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea.
Moon Gyo KimDepartment of Biological Sciences, Inha University, Incheon 402-720, Korea.
Inha University · KRUlsan College · KRWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By combining conventional single cell analysis with flow cytometry and public database searches with bioinformatics tools, we extended the expression profiling of thymic stromal cotransporter (TSCOT), Slc46A2/Ly110, that was shown to be expressed in bipotent precursor and cortical thymic epithelial cells. Genome scale analysis verified TSCOT expression in thymic tissue- and cell type- specific fashion and is also expressed in some other epithelial tissues including skin and lung. Coexpression profiling with genes, Foxn1 and Hoxa3, revealed the role of TSCOT during the organogenesis. TSCOT expression was detected in all thymic epithelial cells (TECs), but not in the CD31(+) endothelial cell lineage in fetal thymus. In addition, ABC transporter-dependent side population and Sca-1(+) fetal TEC populations both contain TSCOT-expressing cells, indicating TEC stem cells express TSCOT. TSCOT expression was identified as early as in differentiating embryonic stem cells. TSCOT expression is not under the control of Foxn1 since TSCOT is present in the thymic rudiment of nude mice. By searching variations in the expression levels, TSCOT is positively associated with Grhl3 and Irf6. Cytokines such as IL1b, IL22 and IL24 are the potential regulators of the TSCOT expression. Surprisingly, we found TSCOT expression in the lung is diminished in lung cancers, suggesting TSCOT may be involved in the suppression of lung tumor development. Based on these results, a model for TEC differentiation from the stem cells was proposed in context of multiple epithelial organ formation.

Indexed as

AnimalsCell DifferentiationEpithelial CellsGene Expression ProfilingGenes, Tumor SuppressorMiceMice, NudePromoter Regions, GeneticStem CellsSymportersThymus GlandSymportersTscot protein, mouseLy110SLC46A2stem cellthymic epithelial cellTSCOTtumor suppressor

Identifiers

PMID26013383
PMCPMC4469913
OpenAlexW1771847669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.